Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
3
×
boston top stories
fda
life sciences
national blog main
san diego blog main
3
×
boston
clinical trials
indiana blog main
new york blog main
raleigh-durham blog main
san diego top stories
san francisco blog main
seattle blog main
startups
vc
venture capital
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
arrowmark partners
asklepios biopharmaceutical
beta bionics
bigfoot biomedical
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
boston university
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
congenital hyperinsulinism
deals
deerfield management
What
developing
3
×
ipo
medicines
million
activity
approvals
beta
bio
biogen
bionics
blood
brings
clamped
closed
company
covid
delays
device
diabetes
disorders
driven
drug
dyne
dyne’s
economic
fast
fda
genetic
heads
including
isn’t
key
levels
lot
manages
medical
monitors
muscle
muscular
new
Language
unset
Current search:
biotech
×
developing
×
" boston blog main "
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
